Clinical Mass Spectrometry Market Size and Growth Rate:
Clinical Mass Spectrometry Market was
valued at USD XX million in 2015 and is estimated to grow at a CAGR of xx% till
2023.
Browse details of 125 number of
pages research report developed on Clinical Mass Spectrometry Market @
https://www.researchcosmos.com/reports/global-clinical-mass-spectrometry-market-trends-competitive-dynamics-and-key-growth-opportunities/1174891020
Clinical Mass Spectrometry Market Growth Drivers and Restraints:
The growing demand of the clinical mass spectrometry in medicine
is a major revolution that has been observed in the last few years. It is a
qualitative and quantitative tool necessary for the assessment of complex
mixtures in the phases of drug development. It allows for the detection of
diseases at an earlier stage, with more accuracy, when the treatment is highly
effective, where the quality of treatment therefore betters for the patient,
and thereby, reduces the overall costs of the treatment.
Rise in aging population, low immunity and rise in diseases has
led to a great boost to the market. Microbial identification, especially, is a
reliable, rapid and cost-effective method for the identification of likely
causes of the disease. Currently, the most common type of diagnosis used is the
LC-MS/MS and the MALDI-TOF. The LC-MS/MS is the vitamin, drug, toxicity
detector while the MALDI-TOF is used for direct tissue analysis.
The clinical mass spectrometer has the ability to analyse a wide
range of samples such as bio marks, proteins or drug molecules, thus making
them an effective tool for medical laboratories. Research in the field of
spectrometry has led to the miniaturization of the tools and increased
automation. However, these tools are expensive and not all healthcare centres
can afford them. They are also manually maintained which makes it highly labour
intensive and unsuitable in case of budget constraints.
Government regulations regarding these tools are stringent and
needs to be certified on quality, resources and workflow before being used in
the clinics. But with its umpteen benefits, the market seems to be looking up
in years to come.
Geographical Analysis
of Clinical Mass Spectrometry Market:
The United States of America holds about 41% of the global
clinical mass spectrometry market share followed by EMEA and Asia Pacific
regions. North America has a number of major players in the region that enable
fast growth with rapid adaptation than other countries. About 7 billion tests
are performed in a year in the US, and because of the accuracy of results with
the mass spectrometer, there has been a spike of activity of all healthcare
centres switching to this option. Europe and Asia Pacific are also investing
heavily in the R&D of this tool to enable the best healthcare services to
the people.
Ask For Free Sample of
the report @ https://www.researchcosmos.com/request/global-clinical-mass-spectrometry-market-trends-competitive-dynamics-and-key-growth-opportunities/1174891020
Key Players of Clinical Mass Spectrometry Market:
Some of the top players in the world market include Thermo Fisher,
AB Sciex, Waters, Agilent, Bruker, Perkin Elmer, Shidmazu and others.
Clinical Mass Spectrometry Market Segmentation:
By Type:
·
LC-MS
·
GC-MS
By End User / Application:
·
Clinical Diagnostics
·
Clinical Research
By Region:
·
North America
·
South America
·
Europe
·
Asia Pacific
·
Middle East and Africa
For
any queries inquire more @ https://www.researchcosmos.com/inquire/global-clinical-mass-spectrometry-market-trends-competitive-dynamics-and-key-growth-opportunities/1174891020
About Us:
Research Cosmos is a provider of standard and
customized market research, business intelligence and consulting services
across more than 100 domains in different industries of the world. We host the
trending market reports of the world’s top-notch publishing companies, offering
services to a wide range of customers from students to fortune 500 companies
and discloses the hidden opportunities in every leading industry of the world.
Contact:
Kevin Stewart
Global Sales
Manager
Research Cosmos
No comments:
Post a Comment